The relation between blood and tissue magnesium levels and development of atrial fibrillation after coronary artery bypass surgery;Koroner arter baypas cerrahisi sonrası atriyal fibrilasyon gelişimi ile doku ve kan magnezyum düzeyleri arasındaki ilişki

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 5, 2010, Pages 446-451

  Şahin, Veysel ^a   Kaplan, Mehmet ^a   Bilsel, Serpil ^b   Filizcan, Uǧur ^a   Çetemen, Şebnem ^a   Bayserke, Olgar ^a   Alkaya, Dilek Bilgiç ^c   Eren, Ergin ^a  

^a Pediatric Cardiac Surgery Clinic   (Turkey)

^b Faculty of Medicine   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Blood magnesium level; Coronary artery bypass grafting; Tissue magnesium level

Indexed keywords

MAGNESIUM;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; MAGNESIUM BLOOD LEVEL; MALE; OBSERVATIONAL STUDY; PATIENT MONITORING; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; TISSUE LEVEL;

EID: 78049336108     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.144     Document Type: Article

References (18)

1. Kalman JM, Munawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995; 60: 1709-15.
2. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-9.
3. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of post-operative atrial arrhythmias. Ann Thorac Surg 1993; 56: 539-49
4. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impacts on hospital resources. Circulation 1996; 94: 390-7.
5. Funk M, Richards SB, Desjardins J, Bebon C, Wilcox H. Incidence, timing, symptoms, and risk factors for atrial fibrillation after cardi-ac surgery. Am J Crit Care 2003; 12: 424-33.
6. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354.
7. Kohno H, Koyanagi T, Kasegawa H, Miyazaki M. Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2005; 79: 117-26.
8. Karmy-Jones R, Hamilton A, Dzavik V, Allegreto M, Finegan BA, Koshal A. Magnesium sulfate prophylaxis after cardiac operations. Ann Thorac Surg 1995; 59: 502-7.
9. England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-con- trolled, double-blind, randomized trial. JAMA 1992; 268: 2395-402.
10. Garcia-Romero E, Castillo-Olivares JL, Figuera D. Prevention of hypomagnesemia and hypocalcemia in open-heart surgery. J Cardivasc Surg 1977; 18:257-60.
11. Spasov AA, Iezhitsa IN, Kharitonova MV, Gurova NA. Arrhythmogenic threshold of the myocardium under conditions of magnesium deficiency. Bull Exp Biol Med 2008; 146: 63-5.
12. Kramer JH, Spurney C, Iantorno M, Tziros C, Mak IT, Tejero-Taldo MI, et al. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 2009; 338: 22-7.
13. Segal JB, McNamara RL, Miller MR, Kim N, Goodman SN, Powe NR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000; 49: 47-59.
14. Boudonas G, Lefkos N, Efthymiadis AP, Styliadis IG, Tsapas G. Intravenous administration of diltiazem in the treatment of supra- ventricular tachyarrhythmias. Acta Cardiol 1995; 50: 125-34.
15. Tamariz LJ, Bass EB. Pharmacological rate control of atrial fibrillation. Cardiol Clin 2004; 22: 35-45.
16. Toraman F, Karabulut EH, Alhan HC, Daǧdelen S, Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001; 72: 1256-61.
17. Manners JM, Nielsen MS. Magnesium flux during open heart surgery. Anesthesia 1981; 36: 157-66.
18. Haigney MC, Silver B, Tanglao E, Silverman HS, Hill JD, Shapiro E, et al. Noninvasive measurement of tissue magnesium and correla-tion with cardiac levels. Circulation 1995; 92: 2190-7.